HZNP - Horizon Therapeutics Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
6.15B
Enterprise Value 3
6.65B
Trailing P/E
130.84
Forward P/E 1
17.02
PEG Ratio (5 yr expected) 1
1.38
Price/Sales (ttm)
4.76
Price/Book (mrq)
3.94
Enterprise Value/Revenue 3
5.15
Enterprise Value/EBITDA 6
57.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 364.78%
S&P500 52-Week Change 321.87%
52 Week High 333.21
52 Week Low 317.94
50-Day Moving Average 330.79
200-Day Moving Average 326.89

Share Statistics

Avg Vol (3 month) 31.31M
Avg Vol (10 day) 31.29M
Shares Outstanding 5187.3M
Float 184.9M
% Held by Insiders 11.20%
% Held by Institutions 182.74%
Shares Short (Nov 29, 2019) 48.5M
Short Ratio (Nov 29, 2019) 46.09
Short % of Float (Nov 29, 2019) 44.65%
Short % of Shares Outstanding (Nov 29, 2019) 44.54%
Shares Short (prior month Oct 31, 2019) 48.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 3.57%
Operating Margin (ttm)8.44%

Management Effectiveness

Return on Assets (ttm)1.76%
Return on Equity (ttm)3.73%

Income Statement

Revenue (ttm)1.29B
Revenue Per Share (ttm)7.25
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)802.57M
EBITDA 115.93M
Net Income Avi to Common (ttm)46.09M
Diluted EPS (ttm)0.25
Quarterly Earnings Growth (yoy)-45.40%

Balance Sheet

Total Cash (mrq)883.96M
Total Cash Per Share (mrq)4.72
Total Debt (mrq)1.38B
Total Debt/Equity (mrq)89.03
Current Ratio (mrq)2.33
Book Value Per Share (mrq)8.33

Cash Flow Statement

Operating Cash Flow (ttm)343.66M
Levered Free Cash Flow (ttm)254.55M